FDA NDC
Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 68788-7787
- Proprietary name
- Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension
- Nonproprietary name
- neomycin and polymyxin B sulfates and hydrocortisone otic
- Labeler
- Preferred Pharmaceuticals, Inc.
- Dosage form
- SUSPENSION
- Strength
- 10 mg/mL
Run it in Rivvi
Which 2027 plans near you dropped or restricted neomycin and polymyxin B sulfates and hydrocortisone otic?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.